AbbVie recently filed a lawsuit against the U.S. Department of Health and Human Services, protesting the inclusion of its botulinum toxin product Botox in the Medicare drug price negotiation list under the Inflation Reduction Act.
Show original
This lawsuit directly targets the core controversy of the federal government's drug pricing policy, highlighting the intense struggle between pharmaceutical companies and regulatory agencies over controlling healthcare costs and ensuring returns on innovation.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Meta spins off $27 billion data center project, audit firm issues warning
格隆汇•2026/02/11 23:56
Bloomberg: An exchange has been asked to disclose testimony records related to an insider trading case
BlockBeats•2026/02/11 23:53
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$67,148.8
-2.47%
Ethereum
ETH
$1,949.41
-3.58%
Tether USDt
USDT
$0.9993
-0.02%
XRP
XRP
$1.37
-1.99%
BNB
BNB
$609.09
-1.75%
USDC
USDC
$0.9998
-0.03%
Solana
SOL
$79.51
-4.38%
TRON
TRX
$0.2782
+0.06%
Dogecoin
DOGE
$0.09136
-1.53%
Bitcoin Cash
BCH
$514.61
-1.84%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now